nodes	percent_of_prediction	percent_of_DWPC	metapath
Oseltamivir—NEU1—myometrium—uterine cancer	0.0307	0.113	CbGeAlD
Oseltamivir—NEU1—uterine cervix—uterine cancer	0.0239	0.0876	CbGeAlD
Oseltamivir—NEU1—smooth muscle tissue—uterine cancer	0.0232	0.0851	CbGeAlD
Oseltamivir—NEU1—decidua—uterine cancer	0.0227	0.0835	CbGeAlD
Oseltamivir—NEU1—endometrium—uterine cancer	0.0216	0.0792	CbGeAlD
Oseltamivir—NEU1—mammalian vulva—uterine cancer	0.0209	0.0766	CbGeAlD
Oseltamivir—NEU1—female gonad—uterine cancer	0.0163	0.0597	CbGeAlD
Oseltamivir—NEU1—vagina—uterine cancer	0.0162	0.0594	CbGeAlD
Oseltamivir—NEU1—lymph node—uterine cancer	0.0105	0.0384	CbGeAlD
Oseltamivir—SLC15A1—epithelium—uterine cancer	0.00898	0.033	CbGeAlD
Oseltamivir—SLC15A1—renal system—uterine cancer	0.00833	0.0306	CbGeAlD
Oseltamivir—SLC15A1—endometrium—uterine cancer	0.00805	0.0296	CbGeAlD
Oseltamivir—SLC15A1—mammalian vulva—uterine cancer	0.00779	0.0286	CbGeAlD
Oseltamivir—CES1—female reproductive system—uterine cancer	0.00719	0.0264	CbGeAlD
Oseltamivir—CES1—female gonad—uterine cancer	0.00654	0.024	CbGeAlD
Oseltamivir—ABCC4—renal system—uterine cancer	0.00604	0.0222	CbGeAlD
Oseltamivir—SLC15A1—vagina—uterine cancer	0.00603	0.0222	CbGeAlD
Oseltamivir—SLC22A8—renal system—uterine cancer	0.00599	0.022	CbGeAlD
Oseltamivir—ABCC4—uterus—uterine cancer	0.00538	0.0198	CbGeAlD
Oseltamivir—ABCC4—female reproductive system—uterine cancer	0.00484	0.0178	CbGeAlD
Oseltamivir—ABCC4—female gonad—uterine cancer	0.0044	0.0162	CbGeAlD
Oseltamivir—CES1—lymph node—uterine cancer	0.00421	0.0154	CbGeAlD
Oseltamivir—CES1—Fluoropyrimidine Activity—RRM2—uterine cancer	0.00338	0.0652	CbGpPWpGaD
Oseltamivir—ABCC4—lymph node—uterine cancer	0.00283	0.0104	CbGeAlD
Oseltamivir—ABCC4—ABC-family proteins mediated transport—ABCC9—uterine cancer	0.0026	0.0502	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—TSPYL2—uterine cancer	0.00187	0.0361	CbGpPWpGaD
Oseltamivir—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00272	CcSEcCtD
Oseltamivir—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00272	CcSEcCtD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—RRM2—uterine cancer	0.00183	0.0352	CbGpPWpGaD
Oseltamivir—Dyspepsia—Progesterone—uterine cancer	0.00182	0.00269	CcSEcCtD
Oseltamivir—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00182	0.00269	CcSEcCtD
Oseltamivir—Herpes simplex—Epirubicin—uterine cancer	0.0018	0.00267	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—RRM2—uterine cancer	0.00179	0.0346	CbGpPWpGaD
Oseltamivir—Delirium—Doxorubicin—uterine cancer	0.00179	0.00265	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Progesterone—uterine cancer	0.00179	0.00264	CcSEcCtD
Oseltamivir—Fatigue—Progesterone—uterine cancer	0.00178	0.00264	CcSEcCtD
Oseltamivir—Pain—Progesterone—uterine cancer	0.00177	0.00262	CcSEcCtD
Oseltamivir—CES1—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.00171	0.033	CbGpPWpGaD
Oseltamivir—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00253	CcSEcCtD
Oseltamivir—Feeling abnormal—Progesterone—uterine cancer	0.0017	0.00252	CcSEcCtD
Oseltamivir—Bone disorder—Doxorubicin—uterine cancer	0.0017	0.00252	CcSEcCtD
Oseltamivir—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.0017	0.00251	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Progesterone—uterine cancer	0.00169	0.0025	CcSEcCtD
Oseltamivir—Herpes simplex—Doxorubicin—uterine cancer	0.00167	0.00247	CcSEcCtD
Oseltamivir—Pneumonia—Etoposide—uterine cancer	0.00167	0.00247	CcSEcCtD
Oseltamivir—Hepatocellular injury—Epirubicin—uterine cancer	0.00166	0.00246	CcSEcCtD
Oseltamivir—Infestation NOS—Etoposide—uterine cancer	0.00166	0.00246	CcSEcCtD
Oseltamivir—Infestation—Etoposide—uterine cancer	0.00166	0.00246	CcSEcCtD
Oseltamivir—Anaemia—Dactinomycin—uterine cancer	0.00166	0.00245	CcSEcCtD
Oseltamivir—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.00244	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00165	0.00243	CcSEcCtD
Oseltamivir—Urticaria—Progesterone—uterine cancer	0.00164	0.00243	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.00164	0.0317	CbGpPWpGaD
Oseltamivir—Abdominal pain—Progesterone—uterine cancer	0.00164	0.00242	CcSEcCtD
Oseltamivir—Body temperature increased—Progesterone—uterine cancer	0.00164	0.00242	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00162	0.00239	CcSEcCtD
Oseltamivir—Jaundice—Etoposide—uterine cancer	0.00162	0.00239	CcSEcCtD
Oseltamivir—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00162	0.00239	CcSEcCtD
Oseltamivir—Influenza like illness—Epirubicin—uterine cancer	0.00161	0.00239	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Etoposide—uterine cancer	0.00157	0.00232	CcSEcCtD
Oseltamivir—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.00229	CcSEcCtD
Oseltamivir—Hepatocellular injury—Doxorubicin—uterine cancer	0.00154	0.00228	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.00227	CcSEcCtD
Oseltamivir—Myalgia—Dactinomycin—uterine cancer	0.00153	0.00226	CcSEcCtD
Oseltamivir—Hypersensitivity—Progesterone—uterine cancer	0.00152	0.00226	CcSEcCtD
Oseltamivir—Influenza like illness—Doxorubicin—uterine cancer	0.00149	0.00221	CcSEcCtD
Oseltamivir—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.0022	CcSEcCtD
Oseltamivir—Asthenia—Progesterone—uterine cancer	0.00148	0.0022	CcSEcCtD
Oseltamivir—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00219	CcSEcCtD
Oseltamivir—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00219	CcSEcCtD
Oseltamivir—Infection—Dactinomycin—uterine cancer	0.00145	0.00215	CcSEcCtD
Oseltamivir—Thrombocytopenia—Dactinomycin—uterine cancer	0.00143	0.00212	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—TSPYL2—uterine cancer	0.00142	0.0273	CbGpPWpGaD
Oseltamivir—Diarrhoea—Progesterone—uterine cancer	0.00142	0.00209	CcSEcCtD
Oseltamivir—Lymphadenopathy—Epirubicin—uterine cancer	0.00141	0.00209	CcSEcCtD
Oseltamivir—Erythema multiforme—Etoposide—uterine cancer	0.00141	0.00208	CcSEcCtD
Oseltamivir—Eye disorder—Etoposide—uterine cancer	0.00139	0.00206	CcSEcCtD
Oseltamivir—Diabetes mellitus—Epirubicin—uterine cancer	0.00139	0.00205	CcSEcCtD
Oseltamivir—Cardiac disorder—Etoposide—uterine cancer	0.00138	0.00205	CcSEcCtD
Oseltamivir—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.00204	CcSEcCtD
Oseltamivir—Hepatic function abnormal—Epirubicin—uterine cancer	0.00138	0.00204	CcSEcCtD
Oseltamivir—Dizziness—Progesterone—uterine cancer	0.00137	0.00202	CcSEcCtD
Oseltamivir—Immune system disorder—Etoposide—uterine cancer	0.00135	0.00199	CcSEcCtD
Oseltamivir—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00199	CcSEcCtD
Oseltamivir—Eczema—Epirubicin—uterine cancer	0.00134	0.00199	CcSEcCtD
Oseltamivir—Hepatic failure—Epirubicin—uterine cancer	0.00134	0.00199	CcSEcCtD
Oseltamivir—Mediastinal disorder—Etoposide—uterine cancer	0.00134	0.00199	CcSEcCtD
Oseltamivir—Eye pain—Epirubicin—uterine cancer	0.00134	0.00198	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00133	0.00197	CcSEcCtD
Oseltamivir—Vomiting—Progesterone—uterine cancer	0.00132	0.00195	CcSEcCtD
Oseltamivir—Lymphadenopathy—Doxorubicin—uterine cancer	0.00131	0.00194	CcSEcCtD
Oseltamivir—Rash—Progesterone—uterine cancer	0.0013	0.00193	CcSEcCtD
Oseltamivir—Dermatitis—Progesterone—uterine cancer	0.0013	0.00193	CcSEcCtD
Oseltamivir—Headache—Progesterone—uterine cancer	0.0013	0.00192	CcSEcCtD
Oseltamivir—Diabetes mellitus—Doxorubicin—uterine cancer	0.00128	0.0019	CcSEcCtD
Oseltamivir—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.0019	CcSEcCtD
Oseltamivir—Hepatic function abnormal—Doxorubicin—uterine cancer	0.00128	0.00189	CcSEcCtD
Oseltamivir—Fatigue—Dactinomycin—uterine cancer	0.00126	0.00187	CcSEcCtD
Oseltamivir—Back pain—Etoposide—uterine cancer	0.00125	0.00186	CcSEcCtD
Oseltamivir—Pain—Dactinomycin—uterine cancer	0.00125	0.00185	CcSEcCtD
Oseltamivir—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00125	0.00185	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.00124	0.024	CbGpPWpGaD
Oseltamivir—Eczema—Doxorubicin—uterine cancer	0.00124	0.00184	CcSEcCtD
Oseltamivir—Hepatic failure—Doxorubicin—uterine cancer	0.00124	0.00184	CcSEcCtD
Oseltamivir—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00183	CcSEcCtD
Oseltamivir—Eye pain—Doxorubicin—uterine cancer	0.00124	0.00183	CcSEcCtD
Oseltamivir—Nausea—Progesterone—uterine cancer	0.00123	0.00182	CcSEcCtD
Oseltamivir—Pain in extremity—Epirubicin—uterine cancer	0.00121	0.00179	CcSEcCtD
Oseltamivir—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.00121	0.00179	CcSEcCtD
Oseltamivir—Feeling abnormal—Dactinomycin—uterine cancer	0.0012	0.00178	CcSEcCtD
Oseltamivir—Anaemia—Etoposide—uterine cancer	0.0012	0.00177	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Dactinomycin—uterine cancer	0.0012	0.00177	CcSEcCtD
Oseltamivir—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00176	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00119	0.0229	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00119	0.0229	CbGpPWpGaD
Oseltamivir—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00175	CcSEcCtD
Oseltamivir—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00175	CcSEcCtD
Oseltamivir—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00174	CcSEcCtD
Oseltamivir—Face oedema—Epirubicin—uterine cancer	0.00117	0.00172	CcSEcCtD
Oseltamivir—Vertigo—Etoposide—uterine cancer	0.00116	0.00172	CcSEcCtD
Oseltamivir—Body temperature increased—Dactinomycin—uterine cancer	0.00116	0.00171	CcSEcCtD
Oseltamivir—Abdominal pain—Dactinomycin—uterine cancer	0.00116	0.00171	CcSEcCtD
Oseltamivir—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00115	0.00171	CcSEcCtD
Oseltamivir—Cough—Etoposide—uterine cancer	0.00113	0.00167	CcSEcCtD
Oseltamivir—Convulsion—Etoposide—uterine cancer	0.00112	0.00166	CcSEcCtD
Oseltamivir—Pain in extremity—Doxorubicin—uterine cancer	0.00112	0.00165	CcSEcCtD
Oseltamivir—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.00112	0.00165	CcSEcCtD
Oseltamivir—Liver function test abnormal—Epirubicin—uterine cancer	0.00111	0.00165	CcSEcCtD
Oseltamivir—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00165	CcSEcCtD
Oseltamivir—Abdominal pain upper—Epirubicin—uterine cancer	0.0011	0.00163	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.0011	0.00162	CcSEcCtD
Oseltamivir—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00109	0.00161	CcSEcCtD
Oseltamivir—Nasopharyngitis—Epirubicin—uterine cancer	0.00108	0.0016	CcSEcCtD
Oseltamivir—Face oedema—Doxorubicin—uterine cancer	0.00108	0.0016	CcSEcCtD
Oseltamivir—Hypersensitivity—Dactinomycin—uterine cancer	0.00108	0.00159	CcSEcCtD
Oseltamivir—Confusional state—Etoposide—uterine cancer	0.00107	0.00158	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—NFE2L2—uterine cancer	0.00106	0.0205	CbGpPWpGaD
Oseltamivir—Anaphylactic shock—Etoposide—uterine cancer	0.00106	0.00157	CcSEcCtD
Oseltamivir—Infection—Etoposide—uterine cancer	0.00105	0.00156	CcSEcCtD
Oseltamivir—Asthenia—Dactinomycin—uterine cancer	0.00105	0.00155	CcSEcCtD
Oseltamivir—Influenza—Epirubicin—uterine cancer	0.00104	0.00154	CcSEcCtD
Oseltamivir—Asthma—Epirubicin—uterine cancer	0.00104	0.00154	CcSEcCtD
Oseltamivir—Thrombocytopenia—Etoposide—uterine cancer	0.00104	0.00153	CcSEcCtD
Oseltamivir—Liver function test abnormal—Doxorubicin—uterine cancer	0.00103	0.00153	CcSEcCtD
Oseltamivir—Skin disorder—Etoposide—uterine cancer	0.00103	0.00152	CcSEcCtD
Oseltamivir—Abdominal pain upper—Doxorubicin—uterine cancer	0.00102	0.00151	CcSEcCtD
Oseltamivir—Angina pectoris—Epirubicin—uterine cancer	0.00102	0.0015	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—GPX3—uterine cancer	0.00101	0.0196	CbGpPWpGaD
Oseltamivir—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00101	0.00149	CcSEcCtD
Oseltamivir—Bronchitis—Epirubicin—uterine cancer	0.001	0.00148	CcSEcCtD
Oseltamivir—Diarrhoea—Dactinomycin—uterine cancer	0.001	0.00148	CcSEcCtD
Oseltamivir—Nasopharyngitis—Doxorubicin—uterine cancer	0.000999	0.00148	CcSEcCtD
Oseltamivir—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000969	0.00143	CcSEcCtD
Oseltamivir—Asthma—Doxorubicin—uterine cancer	0.000965	0.00143	CcSEcCtD
Oseltamivir—Influenza—Doxorubicin—uterine cancer	0.000965	0.00143	CcSEcCtD
Oseltamivir—Angina pectoris—Doxorubicin—uterine cancer	0.00094	0.00139	CcSEcCtD
Oseltamivir—Pneumonia—Epirubicin—uterine cancer	0.000935	0.00138	CcSEcCtD
Oseltamivir—Infestation—Epirubicin—uterine cancer	0.00093	0.00138	CcSEcCtD
Oseltamivir—Infestation NOS—Epirubicin—uterine cancer	0.00093	0.00138	CcSEcCtD
Oseltamivir—Vomiting—Dactinomycin—uterine cancer	0.00093	0.00138	CcSEcCtD
Oseltamivir—Bronchitis—Doxorubicin—uterine cancer	0.000928	0.00137	CcSEcCtD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.000924	0.0178	CbGpPWpGaD
Oseltamivir—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000922	0.00136	CcSEcCtD
Oseltamivir—Rash—Dactinomycin—uterine cancer	0.000922	0.00136	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Etoposide—uterine cancer	0.000914	0.00135	CcSEcCtD
Oseltamivir—Fatigue—Etoposide—uterine cancer	0.000912	0.00135	CcSEcCtD
Oseltamivir—Jaundice—Epirubicin—uterine cancer	0.000907	0.00134	CcSEcCtD
Oseltamivir—Pain—Etoposide—uterine cancer	0.000905	0.00134	CcSEcCtD
Oseltamivir—Conjunctivitis—Epirubicin—uterine cancer	0.000904	0.00134	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000899	0.0173	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000899	0.0173	CbGpPWpGaD
Oseltamivir—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000897	0.00133	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Epirubicin—uterine cancer	0.00088	0.0013	CcSEcCtD
Oseltamivir—Epistaxis—Epirubicin—uterine cancer	0.000877	0.0013	CcSEcCtD
Oseltamivir—Sinusitis—Epirubicin—uterine cancer	0.000873	0.00129	CcSEcCtD
Oseltamivir—Feeling abnormal—Etoposide—uterine cancer	0.000872	0.00129	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000871	0.0168	CbGpPWpGaD
Oseltamivir—Nausea—Dactinomycin—uterine cancer	0.000868	0.00129	CcSEcCtD
Oseltamivir—Pneumonia—Doxorubicin—uterine cancer	0.000866	0.00128	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Etoposide—uterine cancer	0.000865	0.00128	CcSEcCtD
Oseltamivir—Infestation—Doxorubicin—uterine cancer	0.000861	0.00127	CcSEcCtD
Oseltamivir—Infestation NOS—Doxorubicin—uterine cancer	0.000861	0.00127	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000853	0.00126	CcSEcCtD
Oseltamivir—Urticaria—Etoposide—uterine cancer	0.000841	0.00124	CcSEcCtD
Oseltamivir—Jaundice—Doxorubicin—uterine cancer	0.000839	0.00124	CcSEcCtD
Oseltamivir—Abdominal pain—Etoposide—uterine cancer	0.000837	0.00124	CcSEcCtD
Oseltamivir—Body temperature increased—Etoposide—uterine cancer	0.000837	0.00124	CcSEcCtD
Oseltamivir—Conjunctivitis—Doxorubicin—uterine cancer	0.000837	0.00124	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—INHBA—uterine cancer	0.000836	0.0161	CbGpPWpGaD
Oseltamivir—Hepatitis—Epirubicin—uterine cancer	0.000835	0.00124	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000814	0.0012	CcSEcCtD
Oseltamivir—Epistaxis—Doxorubicin—uterine cancer	0.000812	0.0012	CcSEcCtD
Oseltamivir—Sinusitis—Doxorubicin—uterine cancer	0.000807	0.00119	CcSEcCtD
Oseltamivir—Visual impairment—Epirubicin—uterine cancer	0.000805	0.00119	CcSEcCtD
Oseltamivir—Erythema multiforme—Epirubicin—uterine cancer	0.000789	0.00117	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—MME—uterine cancer	0.000786	0.0152	CbGpPWpGaD
Oseltamivir—Eye disorder—Epirubicin—uterine cancer	0.00078	0.00115	CcSEcCtD
Oseltamivir—Hypersensitivity—Etoposide—uterine cancer	0.00078	0.00115	CcSEcCtD
Oseltamivir—Cardiac disorder—Epirubicin—uterine cancer	0.000775	0.00115	CcSEcCtD
Oseltamivir—Hepatitis—Doxorubicin—uterine cancer	0.000773	0.00114	CcSEcCtD
Oseltamivir—Asthenia—Etoposide—uterine cancer	0.000759	0.00112	CcSEcCtD
Oseltamivir—Immune system disorder—Epirubicin—uterine cancer	0.000754	0.00112	CcSEcCtD
Oseltamivir—Mediastinal disorder—Epirubicin—uterine cancer	0.000752	0.00111	CcSEcCtD
Oseltamivir—Arrhythmia—Epirubicin—uterine cancer	0.000746	0.0011	CcSEcCtD
Oseltamivir—Visual impairment—Doxorubicin—uterine cancer	0.000745	0.0011	CcSEcCtD
Oseltamivir—Mental disorder—Epirubicin—uterine cancer	0.000731	0.00108	CcSEcCtD
Oseltamivir—NEU1—Metabolism—NDUFB11—uterine cancer	0.000731	0.0141	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—SRD5A2—uterine cancer	0.000731	0.0141	CbGpPWpGaD
Oseltamivir—Erythema multiforme—Doxorubicin—uterine cancer	0.00073	0.00108	CcSEcCtD
Oseltamivir—Diarrhoea—Etoposide—uterine cancer	0.000724	0.00107	CcSEcCtD
Oseltamivir—Eye disorder—Doxorubicin—uterine cancer	0.000722	0.00107	CcSEcCtD
Oseltamivir—Cardiac disorder—Doxorubicin—uterine cancer	0.000717	0.00106	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.00071	0.0137	CbGpPWpGaD
Oseltamivir—Back pain—Epirubicin—uterine cancer	0.000703	0.00104	CcSEcCtD
Oseltamivir—Dizziness—Etoposide—uterine cancer	0.0007	0.00104	CcSEcCtD
Oseltamivir—Immune system disorder—Doxorubicin—uterine cancer	0.000698	0.00103	CcSEcCtD
Oseltamivir—Mediastinal disorder—Doxorubicin—uterine cancer	0.000696	0.00103	CcSEcCtD
Oseltamivir—Arrhythmia—Doxorubicin—uterine cancer	0.00069	0.00102	CcSEcCtD
Oseltamivir—Mental disorder—Doxorubicin—uterine cancer	0.000677	0.001	CcSEcCtD
Oseltamivir—Vomiting—Etoposide—uterine cancer	0.000673	0.000996	CcSEcCtD
Oseltamivir—Anaemia—Epirubicin—uterine cancer	0.000672	0.000994	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.00067	0.0129	CbGpPWpGaD
Oseltamivir—Agitation—Epirubicin—uterine cancer	0.000668	0.000988	CcSEcCtD
Oseltamivir—Rash—Etoposide—uterine cancer	0.000667	0.000987	CcSEcCtD
Oseltamivir—Dermatitis—Etoposide—uterine cancer	0.000667	0.000986	CcSEcCtD
Oseltamivir—Headache—Etoposide—uterine cancer	0.000663	0.000981	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.00066	0.0127	CbGpPWpGaD
Oseltamivir—Vertigo—Epirubicin—uterine cancer	0.000653	0.000966	CcSEcCtD
Oseltamivir—Back pain—Doxorubicin—uterine cancer	0.000651	0.000963	CcSEcCtD
Oseltamivir—CES1—Fluoropyrimidine Activity—TP53—uterine cancer	0.000649	0.0125	CbGpPWpGaD
Oseltamivir—Cough—Epirubicin—uterine cancer	0.000634	0.000939	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—INHBA—uterine cancer	0.000633	0.0122	CbGpPWpGaD
Oseltamivir—Convulsion—Epirubicin—uterine cancer	0.00063	0.000932	CcSEcCtD
Oseltamivir—Nausea—Etoposide—uterine cancer	0.000629	0.00093	CcSEcCtD
Oseltamivir—Anaemia—Doxorubicin—uterine cancer	0.000622	0.00092	CcSEcCtD
Oseltamivir—Arthralgia—Epirubicin—uterine cancer	0.000619	0.000916	CcSEcCtD
Oseltamivir—Myalgia—Epirubicin—uterine cancer	0.000619	0.000916	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—CDKN2A—uterine cancer	0.000618	0.0119	CbGpPWpGaD
Oseltamivir—Agitation—Doxorubicin—uterine cancer	0.000618	0.000915	CcSEcCtD
Oseltamivir—Anxiety—Epirubicin—uterine cancer	0.000617	0.000913	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000615	0.000909	CcSEcCtD
Oseltamivir—Vertigo—Doxorubicin—uterine cancer	0.000604	0.000894	CcSEcCtD
Oseltamivir—Confusional state—Epirubicin—uterine cancer	0.000598	0.000885	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—MME—uterine cancer	0.000595	0.0115	CbGpPWpGaD
Oseltamivir—Anaphylactic shock—Epirubicin—uterine cancer	0.000593	0.000878	CcSEcCtD
Oseltamivir—Infection—Epirubicin—uterine cancer	0.000589	0.000872	CcSEcCtD
Oseltamivir—Cough—Doxorubicin—uterine cancer	0.000587	0.000868	CcSEcCtD
Oseltamivir—Convulsion—Doxorubicin—uterine cancer	0.000583	0.000862	CcSEcCtD
Oseltamivir—Nervous system disorder—Epirubicin—uterine cancer	0.000582	0.000861	CcSEcCtD
Oseltamivir—Thrombocytopenia—Epirubicin—uterine cancer	0.000581	0.000859	CcSEcCtD
Oseltamivir—Skin disorder—Epirubicin—uterine cancer	0.000576	0.000853	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—NFE2L2—uterine cancer	0.000574	0.0111	CbGpPWpGaD
Oseltamivir—Arthralgia—Doxorubicin—uterine cancer	0.000573	0.000847	CcSEcCtD
Oseltamivir—Myalgia—Doxorubicin—uterine cancer	0.000573	0.000847	CcSEcCtD
Oseltamivir—Anxiety—Doxorubicin—uterine cancer	0.000571	0.000844	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000569	0.000841	CcSEcCtD
Oseltamivir—NEU2—Metabolism—NDUFB11—uterine cancer	0.000554	0.0107	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—SRD5A2—uterine cancer	0.000554	0.0107	CbGpPWpGaD
Oseltamivir—Confusional state—Doxorubicin—uterine cancer	0.000553	0.000819	CcSEcCtD
Oseltamivir—Anaphylactic shock—Doxorubicin—uterine cancer	0.000549	0.000812	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—CDKN1B—uterine cancer	0.000547	0.0106	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—GPX3—uterine cancer	0.000547	0.0106	CbGpPWpGaD
Oseltamivir—Infection—Doxorubicin—uterine cancer	0.000545	0.000807	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00054	0.0008	CcSEcCtD
Oseltamivir—Nervous system disorder—Doxorubicin—uterine cancer	0.000538	0.000797	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000538	0.0104	CbGpPWpGaD
Oseltamivir—Thrombocytopenia—Doxorubicin—uterine cancer	0.000537	0.000795	CcSEcCtD
Oseltamivir—Insomnia—Epirubicin—uterine cancer	0.000537	0.000794	CcSEcCtD
Oseltamivir—Skin disorder—Doxorubicin—uterine cancer	0.000533	0.000789	CcSEcCtD
Oseltamivir—NEU1—Metabolism—AKR1B1—uterine cancer	0.000528	0.0102	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—STAR—uterine cancer	0.000528	0.0102	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000522	0.0101	CbGpPWpGaD
Oseltamivir—Dyspepsia—Epirubicin—uterine cancer	0.000522	0.000773	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—FBXW7—uterine cancer	0.000516	0.00996	CbGpPWpGaD
Oseltamivir—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000512	0.000758	CcSEcCtD
Oseltamivir—Fatigue—Epirubicin—uterine cancer	0.000511	0.000757	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000508	0.0098	CbGpPWpGaD
Oseltamivir—Pain—Epirubicin—uterine cancer	0.000507	0.000751	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.0005	0.00074	CcSEcCtD
Oseltamivir—Insomnia—Doxorubicin—uterine cancer	0.000496	0.000735	CcSEcCtD
Oseltamivir—Feeling abnormal—Epirubicin—uterine cancer	0.000489	0.000723	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Epirubicin—uterine cancer	0.000485	0.000718	CcSEcCtD
Oseltamivir—Dyspepsia—Doxorubicin—uterine cancer	0.000483	0.000715	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—EP300—uterine cancer	0.000481	0.00927	CbGpPWpGaD
Oseltamivir—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000474	0.000701	CcSEcCtD
Oseltamivir—Fatigue—Doxorubicin—uterine cancer	0.000473	0.0007	CcSEcCtD
Oseltamivir—Urticaria—Epirubicin—uterine cancer	0.000471	0.000697	CcSEcCtD
Oseltamivir—Pain—Doxorubicin—uterine cancer	0.000469	0.000695	CcSEcCtD
Oseltamivir—Body temperature increased—Epirubicin—uterine cancer	0.000469	0.000694	CcSEcCtD
Oseltamivir—Abdominal pain—Epirubicin—uterine cancer	0.000469	0.000694	CcSEcCtD
Oseltamivir—Feeling abnormal—Doxorubicin—uterine cancer	0.000452	0.000669	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000449	0.000664	CcSEcCtD
Oseltamivir—Hypersensitivity—Epirubicin—uterine cancer	0.000437	0.000647	CcSEcCtD
Oseltamivir—Urticaria—Doxorubicin—uterine cancer	0.000436	0.000645	CcSEcCtD
Oseltamivir—Abdominal pain—Doxorubicin—uterine cancer	0.000434	0.000642	CcSEcCtD
Oseltamivir—Body temperature increased—Doxorubicin—uterine cancer	0.000434	0.000642	CcSEcCtD
Oseltamivir—Asthenia—Epirubicin—uterine cancer	0.000426	0.00063	CcSEcCtD
Oseltamivir—NEU1—Metabolism—POLD1—uterine cancer	0.000415	0.008	CbGpPWpGaD
Oseltamivir—Diarrhoea—Epirubicin—uterine cancer	0.000406	0.000601	CcSEcCtD
Oseltamivir—Hypersensitivity—Doxorubicin—uterine cancer	0.000404	0.000598	CcSEcCtD
Oseltamivir—NEU2—Metabolism—AKR1B1—uterine cancer	0.0004	0.00772	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—STAR—uterine cancer	0.0004	0.00772	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000396	0.00763	CbGpPWpGaD
Oseltamivir—Asthenia—Doxorubicin—uterine cancer	0.000394	0.000583	CcSEcCtD
Oseltamivir—Dizziness—Epirubicin—uterine cancer	0.000392	0.00058	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—FBXW7—uterine cancer	0.000391	0.00755	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—AKR1C1—uterine cancer	0.000388	0.00748	CbGpPWpGaD
Oseltamivir—Vomiting—Epirubicin—uterine cancer	0.000377	0.000558	CcSEcCtD
Oseltamivir—Diarrhoea—Doxorubicin—uterine cancer	0.000376	0.000556	CcSEcCtD
Oseltamivir—Rash—Epirubicin—uterine cancer	0.000374	0.000553	CcSEcCtD
Oseltamivir—Dermatitis—Epirubicin—uterine cancer	0.000374	0.000553	CcSEcCtD
Oseltamivir—Headache—Epirubicin—uterine cancer	0.000372	0.00055	CcSEcCtD
Oseltamivir—Dizziness—Doxorubicin—uterine cancer	0.000363	0.000537	CcSEcCtD
Oseltamivir—Nausea—Epirubicin—uterine cancer	0.000352	0.000521	CcSEcCtD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—TP53—uterine cancer	0.000351	0.00676	CbGpPWpGaD
Oseltamivir—Vomiting—Doxorubicin—uterine cancer	0.000349	0.000516	CcSEcCtD
Oseltamivir—Rash—Doxorubicin—uterine cancer	0.000346	0.000512	CcSEcCtD
Oseltamivir—Dermatitis—Doxorubicin—uterine cancer	0.000346	0.000512	CcSEcCtD
Oseltamivir—NEU1—Metabolism—RRM2—uterine cancer	0.000346	0.00667	CbGpPWpGaD
Oseltamivir—Headache—Doxorubicin—uterine cancer	0.000344	0.000509	CcSEcCtD
Oseltamivir—NEU1—Metabolism—DCN—uterine cancer	0.000336	0.00647	CbGpPWpGaD
Oseltamivir—Nausea—Doxorubicin—uterine cancer	0.000326	0.000482	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000319	0.00615	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYP11A1—uterine cancer	0.000316	0.0061	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—POLD1—uterine cancer	0.000314	0.00606	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—FGFR2—uterine cancer	0.000305	0.00589	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—AKR1C3—uterine cancer	0.000299	0.00576	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—AKR1C1—uterine cancer	0.000294	0.00567	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000284	0.00547	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000272	0.00525	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—CCL2—uterine cancer	0.000265	0.00512	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—RRM2—uterine cancer	0.000262	0.00505	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—DCN—uterine cancer	0.000254	0.00491	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP11A1—uterine cancer	0.00024	0.00462	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYP19A1—uterine cancer	0.000233	0.00449	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—STK11—uterine cancer	0.000233	0.00449	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—CCL2—uterine cancer	0.00023	0.00444	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—VEGFA—uterine cancer	0.000229	0.00441	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—AKR1C3—uterine cancer	0.000226	0.00436	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000218	0.00421	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	0.000218	0.0042	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—CXCL8—uterine cancer	0.00021	0.00405	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000208	0.00402	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—CCL2—uterine cancer	0.000201	0.00388	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—CTNNB1—uterine cancer	0.000194	0.00373	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IRF1—uterine cancer	0.000177	0.00341	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—STK11—uterine cancer	0.000176	0.0034	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP19A1—uterine cancer	0.000176	0.0034	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—MTHFR—uterine cancer	0.000175	0.00337	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—CTNNB1—uterine cancer	0.000168	0.00324	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000165	0.00319	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—CXCL8—uterine cancer	0.000159	0.00307	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000158	0.00304	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000154	0.00297	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—CTNNB1—uterine cancer	0.000147	0.00283	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—MTHFR—uterine cancer	0.000132	0.00255	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000117	0.00225	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	0.000101	0.00196	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTEN—uterine cancer	9.72e-05	0.00188	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—EP300—uterine cancer	9.27e-05	0.00179	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	7.92e-05	0.00153	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTEN—uterine cancer	7.37e-05	0.00142	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—EP300—uterine cancer	7.03e-05	0.00136	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CA—uterine cancer	6.86e-05	0.00132	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—AKT1—uterine cancer	6.47e-05	0.00125	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—AKT1—uterine cancer	5.6e-05	0.00108	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—EP300—uterine cancer	5.52e-05	0.00106	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—VEGFA—uterine cancer	5.22e-05	0.00101	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CA—uterine cancer	5.2e-05	0.001	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—NRAS—uterine cancer	5.16e-05	0.000995	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—KRAS—uterine cancer	4.44e-05	0.000857	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—AKT1—uterine cancer	4.25e-05	0.000819	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CA—uterine cancer	4.08e-05	0.000787	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TP53—uterine cancer	3.95e-05	0.000761	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—HRAS—uterine cancer	3.78e-05	0.000728	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—AKT1—uterine cancer	3.33e-05	0.000643	CbGpPWpGaD
